MARKET

ELXMF

ELXMF

Nova Eye Medical Limited
OTCPK
0.0019
NaN%
Opening 09:30 02/09 EST
OPEN
--
PREV CLOSE
0.0019
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.100
52 WEEK LOW
0.0019
MARKET CAP
541.18K
P/E (TTM)
-0.0792
1D
5D
1M
3M
1Y
5Y
1D
Nova Eye Medical Sets Investor Webinar to Present Quarterly Results and iTrack Update
TipRanks · 01/29 05:30
Nova Eye Medical Posts Record Quarter as iTrack Sales Surge
TipRanks · 01/28 23:09
Nova Eye Reports Strong Real-World Outcomes From Global iTrack Glaucoma Registry
TipRanks · 01/27 01:18
Nova Eye sets investor webinar to discuss December 2025 sales and glaucoma focus
TipRanks · 01/19 00:37
Nova Eye Medical Sets Investor Webinar to Deliver Half-Year Sales Update
TipRanks · 01/14 22:53
Nova Eye Posts Record Quarter as U.S. Glaucoma Device Sales Surge
TipRanks · 01/11 23:38
Nova Eye Medical to Quote New Securities on ASX
TipRanks · 12/05/2025 01:18
Nova Eye Medical’s AGM Resolutions Receive Strong Shareholder Support
TipRanks · 11/27/2025 04:17
More
About ELXMF
Nova Eye Medical Limited is an Australia-based medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. The Company operates through two segments: AlphaRET, and Glaucoma surgical devices. The Company’s AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser, which is a treatment to delay progression to late-stage age-related macular degeneration (AMD) for patients who have the disease in its intermediate stage. 2RT is a patented nano-pulse laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the designing, manufacturing, marketing, and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device. The Molteno3 glaucoma drainage device platform is designed to enhance surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma.

Webull offers Nova Eye Medical Ltd stock information, including OTCPK: ELXMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELXMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELXMF stock methods without spending real money on the virtual paper trading platform.